Onconetix Inc (ONCO)
1.64
-0.08
(-4.65%)
USD |
NASDAQ |
Nov 14, 16:00
1.74
+0.10
(+6.10%)
After-Hours: 20:00
Onconetix Profit Margin (Quarterly): -2.03K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.03K% |
| March 31, 2024 | -1.59K% |
| Date | Value |
|---|---|
| December 31, 2023 | -38.23K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-38.23K%
Minimum
Dec 2023
-1.59K%
Maximum
Mar 2024
-13.95K%
Average
-2.03K%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | -3.67K% |
| IGC Pharma Inc | -874.3% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Protalix BioTherapeutics Inc | -16.35% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | 14.29% |
| Operating Margin (Quarterly) | -300.3% |